-
Je něco špatně v tomto záznamu ?
Hydrogen sulfide alleviates lipopolysaccharide-induced myocardial injury through TLR4-NLRP3 pathway
Y. Xia, W. Zhang, K. He, L. Bai, Y. Miao, B. Liu, X. Zhang, S. Jin, Y. Wu
Jazyk angličtina Země Česko
Typ dokumentu časopisecké články
NLK
Directory of Open Access Journals
od 1991
Free Medical Journals
od 1998
PubMed Central
od 2020
ProQuest Central
od 2005-01-01
Medline Complete (EBSCOhost)
od 2006-01-01
Nursing & Allied Health Database (ProQuest)
od 2005-01-01
Health & Medicine (ProQuest)
od 2005-01-01
ROAD: Directory of Open Access Scholarly Resources
od 1998
- MeSH
- funkce levé komory srdeční MeSH
- kardiomyopatie * MeSH
- lipopolysacharidy toxicita MeSH
- myši inbrední C57BL MeSH
- myši MeSH
- poranění srdce * MeSH
- protein NLRP3 MeSH
- sepse * chemicky indukované komplikace farmakoterapie MeSH
- sulfan * farmakologie terapeutické užití MeSH
- tepový objem MeSH
- TNF-alfa MeSH
- toll-like receptor 4 metabolismus MeSH
- zánět patologie MeSH
- zvířata MeSH
- Check Tag
- mužské pohlaví MeSH
- myši MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
To investigate the effect of hydrogen sulfide (H2S) on myocardial injury in sepsis-induced myocardial dysfunction (SIMD), male C57BL/6 mice were intraperitoneally injected with lipopolysaccharide (LPS) (10 mg/kg, i.p.) to induce cardiac dysfunction without or with the H2S donor sodium hydrosulfide (NaHS) (50 μmol/kg, i.p.) administration 3 h after LPS injection. Six hours after the LPS injection, echocardiography, cardiac hematoxylin and eosin (HE) staining, myocardial damage and inflammatory biomarkers and Western blot results were analyzed. In mice, the administration of LPS decreased left ventricular ejection fraction (LVEF) by 30 % along with lowered H2S levels (35 % reduction). It was observed that cardiac troponin I (cTnI), tumor necrosis factor-alpha (TNF-alpha), and interleukin-1beta (IL-1beta) levels were all increased (by 0.22-fold, 2000-fold and 0.66-fold respectively). HE staining revealed structural damage and inflammatory cell infiltration in the myocardial tissue after LPS administration. Moreover, after 6 h of LPS treatment, toll-like receptor 4 (TLR4) and nod-like receptor protein 3 (NLRP3) expressions were up-regulated 2.7-fold and 1.6-fold respectively. When compared to the septic mice, NaHS enhanced ventricular function (by 0.19-fold), decreased cTnI, TNF-alpha, and IL-1beta levels (by 11 %, 33 %, and 16 % respectively) and downregulated TLR4 and NLRP3 expressions (by 64 % and 31 % respectively). Furthermore, NaHS did not further improve cardiac function and inflammation in TLR4-/- mice or mice in which NLRP3 activation was inhibited by MCC950, after LPS injection. In conclusion, these findings imply that decreased endogenous H2S promotes the progression of SIMD, whereas exogenous H2S alleviates SIMD by inhibiting inflammation via the TLR4-NLRP3 pathway suppression.
Department of Physiology Hebei Medical University Hebei China
Hebei Collaborative Innovation Center for Cardio Cerebrovascular Disease Hebei China
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23002228
- 003
- CZ-PrNML
- 005
- 20230517133808.0
- 007
- ta
- 008
- 230406s2023 xr ad f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.33549/physiolres.934928 $2 doi
- 035 __
- $a (PubMed)36545872
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Xia, Yuxuan $u Department of Physiology, Hebei Medical University, Hebei, China
- 245 10
- $a Hydrogen sulfide alleviates lipopolysaccharide-induced myocardial injury through TLR4-NLRP3 pathway / $c Y. Xia, W. Zhang, K. He, L. Bai, Y. Miao, B. Liu, X. Zhang, S. Jin, Y. Wu
- 520 9_
- $a To investigate the effect of hydrogen sulfide (H2S) on myocardial injury in sepsis-induced myocardial dysfunction (SIMD), male C57BL/6 mice were intraperitoneally injected with lipopolysaccharide (LPS) (10 mg/kg, i.p.) to induce cardiac dysfunction without or with the H2S donor sodium hydrosulfide (NaHS) (50 μmol/kg, i.p.) administration 3 h after LPS injection. Six hours after the LPS injection, echocardiography, cardiac hematoxylin and eosin (HE) staining, myocardial damage and inflammatory biomarkers and Western blot results were analyzed. In mice, the administration of LPS decreased left ventricular ejection fraction (LVEF) by 30 % along with lowered H2S levels (35 % reduction). It was observed that cardiac troponin I (cTnI), tumor necrosis factor-alpha (TNF-alpha), and interleukin-1beta (IL-1beta) levels were all increased (by 0.22-fold, 2000-fold and 0.66-fold respectively). HE staining revealed structural damage and inflammatory cell infiltration in the myocardial tissue after LPS administration. Moreover, after 6 h of LPS treatment, toll-like receptor 4 (TLR4) and nod-like receptor protein 3 (NLRP3) expressions were up-regulated 2.7-fold and 1.6-fold respectively. When compared to the septic mice, NaHS enhanced ventricular function (by 0.19-fold), decreased cTnI, TNF-alpha, and IL-1beta levels (by 11 %, 33 %, and 16 % respectively) and downregulated TLR4 and NLRP3 expressions (by 64 % and 31 % respectively). Furthermore, NaHS did not further improve cardiac function and inflammation in TLR4-/- mice or mice in which NLRP3 activation was inhibited by MCC950, after LPS injection. In conclusion, these findings imply that decreased endogenous H2S promotes the progression of SIMD, whereas exogenous H2S alleviates SIMD by inhibiting inflammation via the TLR4-NLRP3 pathway suppression.
- 650 _2
- $a myši $7 D051379
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a zvířata $7 D000818
- 650 12
- $a sulfan $x farmakologie $x terapeutické užití $7 D006862
- 650 _2
- $a lipopolysacharidy $x toxicita $7 D008070
- 650 _2
- $a protein NLRP3 $7 D000071199
- 650 _2
- $a TNF-alfa $7 D014409
- 650 _2
- $a toll-like receptor 4 $x metabolismus $7 D051197
- 650 _2
- $a tepový objem $7 D013318
- 650 _2
- $a funkce levé komory srdeční $7 D016277
- 650 _2
- $a myši inbrední C57BL $7 D008810
- 650 _2
- $a zánět $x patologie $7 D007249
- 650 12
- $a sepse $x chemicky indukované $x komplikace $x farmakoterapie $7 D018805
- 650 12
- $a kardiomyopatie $7 D009202
- 650 12
- $a poranění srdce $7 D006335
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Zhang, Wenya $u Department of Physiology, Hebei Medical University, Hebei, China
- 700 1_
- $a He, Kaichuan $u Department of Physiology, Hebei Medical University, Hebei, China
- 700 1_
- $a Bai, Lu $u Department of Physiology, Hebei Medical University, Hebei, China
- 700 1_
- $a Miao, Yuxin $u Department of Physiology, Hebei Medical University, Hebei, China
- 700 1_
- $a Liu, Biyu $u Department of Physiology, Hebei Medical University, Hebei, China
- 700 1_
- $a Zhang, Xiangjian $u Hebei Collaborative Innovation Center for Cardio-Cerebrovascular Disease, Hebei, China
- 700 1_
- $a Jin, Sheng $u Department of Physiology, Hebei Medical University, Hebei, China
- 700 1_
- $a Wu, Yuming $u Department of Physiology, Hebei Medical University, Hebei, China $u Hebei Collaborative Innovation Center for Cardio-Cerebrovascular Disease, Hebei, China
- 773 0_
- $w MED00003824 $t Physiological research $x 1802-9973 $g Roč. 72, č. 1 (2023), s. 15-25
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/36545872 $y Pubmed
- 910 __
- $a ABA008 $b A 4120 $c 266 $y p $z 0
- 990 __
- $a 20230406 $b ABA008
- 991 __
- $a 20230517133803 $b ABA008
- 999 __
- $a ok $b bmc $g 1933556 $s 1188434
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2023 $b 72 $c 1 $d 15-25 $e 20221222 $i 1802-9973 $m Physiological research $n Physiol. Res. (Print) $x MED00003824
- LZP __
- $b NLK198 $a Pubmed-20230406